The classification of steatotic liver disease (SLD) is undergoing a major conceptual transformation. In a recent article ...

Around 3 million people worldwide struggle with chronic pancreatitis, a condition in which the pancreas becomes inflamed, ...

The Sacramento Zoo is mourning the death of Makan, its male Sumatran orangutan. Zoo officials said Makan died Monday after ...

Patients with cystic fibrosis often reduce or discontinue respiratory cotherapies after starting CFTR modulators without affecting clinical status.

A generic formulation of elexacaftor-tezacaftor-ivacaftor shows real-world benefits and appears safe in children and ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

Even after the introduction of ETI for cystic fibrosis, habit continues to have a key role in adherence to inhaled medicines in patients with CF.

Delve into bronchiectasis, a field long focused on managing symptoms that now has its first targeted treatment with ...

The research group led by CIC biomaGUNE's Ikerbasque Research Professor Aitziber L. Cortajarena has developed an innovative ...

Princess Mette-Marit of Norway has undergone a lung transplant to treat a progressive lung disease called chronic pulmonary ...

The research group led by CIC biomaGUNE's Ikerbasque Research Professor Aitziber L. Cortajarena has developed an innovative ...